Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021

G. Thompson, Mark; L. Burgess, Jefferey; L. Naleway, Allison; L. Tyner, Harmony; K. Yoon, Sarang; K. Meece, Jennifer; E.W. Olsho, Lauren; J. Caban‐Martinez, Alberto; Fowlkes, Ashley; Lutrick, Karen; L. Kuntz, Jennifer; Dunnigan, Kayan; J. Odean, Marilyn; T. Hegmann, Kurt; Stefanski, Elisha; Edwards, Laura; Schaefer Solle, Natasha; Grant, Lauren; Ellingson, Katherine; C. Groom, Holly; Zunie, Tnelda; S. Thiese, Matthew; Ivacic, Lynn; G. Wesley, Meredith; Mayo Lamberte, Julie; Sun, Xiaoxiao; Smith, Michael; L. Phillips, Andrew; Groover, Kimberly; M. Yoo, Young; K. Gerald, Joe; T. Brown, Rachel; K. Herring, Meghan; Joseph, Gregory; C. Beitel, Shawn; Morrill, Tyler; Mak, Josephine; Rivers, Patrick; M. Harris, Katherine; Rentz Hunt, Danielle; Arvay, Melissa; K. Kutty, Preeta; M. Fry, Alicia; Gaglani, Manjusha

doi:10.15585/mmwr.mm7013e3

Public

Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021

Published in MMWR Morbidity and Mortality Weekly Report • Mar 29, 2021

Authors:

Mark G. Thompson

Jefferey L. Burgess

Allison L. Naleway

Abstract

In contrast, among fully immunized (≥14 days after second dose) persons, 0.04 infections per 1,000 person-days were reported, and among partially immunized (≥14 days after first dose and before second dose) persons, 0.19 infections per 1,000 person-days were reported. Estimated mRNA vaccine effectiv...

Subject

Medicine

Interim

Immunization

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!